文献速递传染病防控与疫情报告卫生政策与健康促进

布里斯托注射吸毒者社区相关MRSA克隆扩张:2012至2017年

Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017.
PubMed 文献 · Euro Surveill · 2019-01-01

2015年布里斯托注射吸毒者MRSA感染病例大幅增加,2016年社区调查显示MRSA定植率为8.7%(13/149),并与公共场所注射、近期医疗接触及三人以上集体注射相关;全基因组测序证实ST5-SCCmecIVg优势克隆在注射吸毒者中扩张和传播。

要点

  • 注射吸毒者MRSA定植率8.7%,高于一般人群估计。
  • 公共场所注射、近期医疗接触及三人以上集体注射与定植相关。
  • ST5-SCCmecIVg克隆在布里斯托注射吸毒者中扩张传播。

核心结论

  • 布里斯托注射吸毒者MRSA定植率显著高于一般人群估计,存在克隆扩张、社区传播及定植菌株相关感染风险增加。

研究设计与样本

  • 2016年通过非关联匿名社区调查招募注射吸毒者,完成行为问卷并筛查MRSA,采用单因素logistic回归分析定植相关因素。
  • 对谱系匹配的MRSA分离株进行全基因组测序,比较注射吸毒者(2012至2017年筛查及回顾性菌血症样本)与非注射吸毒者(布里斯托筛查)及国家参考实验室数据库样本。

主要发现

  • MRSA定植率为8.7%(13/149)。
  • 公共场所频繁注射与定植相关(OR:5.5;95%CI:1.34-22.70)。
  • 近期医疗接触与定植相关(OR:4.3;95%CI:1.34-13.80)。
  • 三人以上集体注射与定植相关(OR:15.8;95%CI:2.51-99.28)。
  • 报告公共场所注射、注射部位皮肤软组织感染或医院接触任一项者覆盖12/13例MRSA阳性(敏感性92.3%;特异性51.5%)。

临床怎么用

  • 针对注射吸毒者开展社区筛查和抑制治疗、教育及基础感染控制以减少MRSA感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2015, Bristol (South West England) experienced a large increase in cases of meticillin-resistant Staphylococcus aureus (MRSA) infection in people who inject drugs (PWID). AIM: We aimed to characterise and estimate the prevalence of MRSA colonisation among PWID in Bristol and test evidence of a clonal outbreak. METHODS: PWID recruited through an unlinked-anonymous community survey during 2016 completed behavioural questionnaires and were screened for MRSA. Univariable logistic regression examined associations with MRSA colonisation. Whole-genome sequencing used lineage-matched MRSA isolates, comparing PWID (screening and retrospective bacteraemia samples from 2012-2017) with non-PWID (Bristol screening) in Bristol and national reference laboratory database samples. RESULTS: The MRSA colonisation prevalence was 8.7% (13/149) and was associated with frequently injecting in public places (odds ratio (OR): 5.5; 95% confidence interval (CI):1.34-22.70), recent healthcare contact (OR: 4.3; 95% CI: 1.34-13.80) and injecting in groups of three or more (OR: 15.8; 95% CI: 2.51-99.28). People reporting any one of: injecting in public places, injection site skin and soft tissue infection or hospital contact accounted for 12/13 MRSA positive cases (sensitivity 92.3%; specificity 51.5%). Phylogenetic analysis identified a dominant clade associated with infection and colonisation among PWID in Bristol belonging to ST5-SCCmecIVg. CONCLUSIONS: MRSA colonisation in Bristol PWID is substantially elevated compared with general population estimates and there is evidence of clonal expansion, community-based transmission and increased infection risk related to the colonising strain. Targeted interventions, including community screening and suppression therapy, education and basic infection control are needed to reduce MRSA infections in PWID.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Packer S, Pichon B, Thompson S, et al. Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017. Euro Surveill. 2019. PMID: 30940316. doi:10.2807/1560-7917.ES.2019.24.13.1800124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。